KEROS THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.94 USD | -1.97% |
|
-9.70% | +33.27% |
| 05-08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
| 05-08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KEROS THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.73% | -9.70% | +33.27% | +12.88% | - | 1.95B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KROS Stock
- Charts Keros Therapeutics, Inc.
- Comparison Chart
